한글목차

개요

액체 충전 하드 캡슐 시장은 2023-2028년간 10억 8,575만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 7.68%를 나타낼 것으로 예측됩니다.

액체 충전 하드 캡슐 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 고령자 인구와 만성질환 증가, 경구제의 선호도 증가, 환자 중심 약물전달에 대한 주목 증가 등에 의해 시장 성장이 촉진되고 있습니다.

본 조사에서는 향후 몇 년간 액체 충전 하드 캡슐 시장 성장을 가속하는 주요인 중 하나로서 캡슐 충전 장비 기술의 발전을 들고 있습니다. 보충제나 제약 업계에서의 식물 유래/천연 유래 제품 채택 증가, 클린 라벨 제품은 시장의 높은 수요로 연결될 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 액체 충전 하드 캡슐 시장(2018-2022년)
• 유형별 부문 분석(2018-2022년)
• 최종사용자별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 유형별

• 시장 부문
• 비교 : 유형별
• 중 : 시장 규모와 예측(2023-2028년)
• 소 : 시장 규모와 예측(2023-2028년)
• 대 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 유형별

제7장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 제약회사 및 CMO : 시장 규모와 예측(2023-2028년)
• 식이보충제 회사 및 식이보충제 제조업체 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 최종사용자별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 일본 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역별

제10장 성장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• ACG
• Ajix Inc.
• Altasciences
• Erawat Pharma Ltd.
• Farmacapsulas S.A.
• Lefancaps LTD.
• Lonza Group Ltd.
• Mitsubishi Chemical Group Corp.
• Nectar Lifesciences Ltd.
• Roxlor LLC
• Sirio Pharma Co. Ltd.
• Suheung Co. Ltd.
• Sunil Healthcare Ltd.
• Thermo Fisher Scientific Inc.
• Zeon Lifesciences Ltd.

제13장 부록

영문목차

Abstract

The liquid filled hard capsules market is forecasted to grow by USD 1085.75 mn during 2023-2028, accelerating at a CAGR of 7.68% during the forecast period. The report on the liquid filled hard capsules market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increasing geriatric population and chronic diseases, a rising preference for oral dosage forms, and a growing focus on patient-centric drug delivery.

Technavio's liquid filled hard capsules market is segmented as below:

By Type

• Medium
• Small
• Large

By End-user

• Pharmaceutical companies
• CMO
• Nutraceutical companies and dietary supplement manufacturers

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the technological advancements in capsule-filling equipment as one of the prime reasons driving the liquid filled hard capsules market growth during the next few years. Also, the rise in the adoption of plant-based and natural products in supplement and pharmaceutical industries and the growing trend toward clean-label products will lead to sizable demand in the market.

The report on the liquid filled hard capsules market covers the following areas:

• Liquid filled hard capsules market sizing
• Liquid filled hard capsules market forecast
• Liquid filled hard capsules market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading liquid filled hard capsules market vendors that include ACG, Ajix Inc., Altasciences, Bright Pharma Caps Inc., Catalent Inc., CPG Fusion Bioscience Manufacturing Inc., Erawat Pharma Ltd., Farmacapsulas S.A., Fermentis Life Sciences Pvt. Ltd., Fine USA Trading Inc., Healthcaps India Ltd., Lefancaps LTD., Lonza Group Ltd., Mitsubishi Chemical Group Corp., Nectar Lifesciences Ltd., PLX Pharma Inc., Roxlor LLC, Sirio Pharma Co. Ltd., Suheung Co. Ltd., Sunil Healthcare Ltd., Supplement Manufacturing Partner, Thermo Fisher Scientific Inc., and Zeon Lifesciences Ltd.. Also, the liquid filled hard capsules market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global liquid filled hard capsules market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global liquid filled hard capsules market 2018 - 2022 ($ million)
• 4.2 Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 End-user Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Medium - Market size and forecast 2023-2028
• Exhibit 34: Chart on Medium - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Medium - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Medium - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Medium - Year-over-year growth 2023-2028 (%)
• 6.4 Small - Market size and forecast 2023-2028
• Exhibit 38: Chart on Small - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Small - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Small - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Small - Year-over-year growth 2023-2028 (%)
• 6.5 Large - Market size and forecast 2023-2028
• Exhibit 42: Chart on Large - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Large - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Large - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Large - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Type
• Exhibit 46: Market opportunity by Type ($ million)
• Exhibit 47: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
• 7.2 Comparison by End-user
• Exhibit 50: Chart on Comparison by End-user
• Exhibit 51: Data Table on Comparison by End-user
• 7.3 Pharmaceutical companies and CMO - Market size and forecast 2023-2028
• Exhibit 52: Chart on Pharmaceutical companies and CMO - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Pharmaceutical companies and CMO - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Pharmaceutical companies and CMO - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Pharmaceutical companies and CMO - Year-over-year growth 2023-2028 (%)
• 7.4 Nutraceutical companies and dietary supplement manufacturers - Market size and forecast 2023-2028
• Exhibit 56: Chart on Nutraceutical companies and dietary supplement manufacturers - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Nutraceutical companies and dietary supplement manufacturers - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Nutraceutical companies and dietary supplement manufacturers - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Nutraceutical companies and dietary supplement manufacturers - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by End-user
• Exhibit 60: Market opportunity by End-user ($ million)
• Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share by geography 2023-2028 (%)
• Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
• Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
• Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity by geography
• Exhibit 103: Market opportunity by geography ($ million)
• Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 ACG
• Exhibit 111: ACG - Overview
• Exhibit 112: ACG - Product / Service
• Exhibit 113: ACG - Key offerings
• 12.4 Ajix Inc.
• Exhibit 114: Ajix Inc. - Overview
• Exhibit 115: Ajix Inc. - Product / Service
• Exhibit 116: Ajix Inc. - Key news
• Exhibit 117: Ajix Inc. - Key offerings
• 12.5 Altasciences
• Exhibit 118: Altasciences - Overview
• Exhibit 119: Altasciences - Product / Service
• Exhibit 120: Altasciences - Key offerings
• 12.6 Erawat Pharma Ltd.
• Exhibit 121: Erawat Pharma Ltd. - Overview
• Exhibit 122: Erawat Pharma Ltd. - Product / Service
• Exhibit 123: Erawat Pharma Ltd. - Key offerings
• 12.7 Farmacapsulas S.A.
• Exhibit 124: Farmacapsulas S.A. - Overview
• Exhibit 125: Farmacapsulas S.A. - Product / Service
• Exhibit 126: Farmacapsulas S.A. - Key offerings
• 12.8 Lefancaps LTD.
• Exhibit 127: Lefancaps LTD. - Overview
• Exhibit 128: Lefancaps LTD. - Product / Service
• Exhibit 129: Lefancaps LTD. - Key offerings
• 12.9 Lonza Group Ltd.
• Exhibit 130: Lonza Group Ltd. - Overview
• Exhibit 131: Lonza Group Ltd. - Business segments
• Exhibit 132: Lonza Group Ltd. - Key news
• Exhibit 133: Lonza Group Ltd. - Key offerings
• Exhibit 134: Lonza Group Ltd. - Segment focus
• 12.10 Mitsubishi Chemical Group Corp.
• Exhibit 135: Mitsubishi Chemical Group Corp. - Overview
• Exhibit 136: Mitsubishi Chemical Group Corp. - Business segments
• Exhibit 137: Mitsubishi Chemical Group Corp. - Key offerings
• Exhibit 138: Mitsubishi Chemical Group Corp. - Segment focus
• 12.11 Nectar Lifesciences Ltd.
• Exhibit 139: Nectar Lifesciences Ltd. - Overview
• Exhibit 140: Nectar Lifesciences Ltd. - Product / Service
• Exhibit 141: Nectar Lifesciences Ltd. - Key offerings
• 12.12 Roxlor LLC
• Exhibit 142: Roxlor LLC - Overview
• Exhibit 143: Roxlor LLC - Product / Service
• Exhibit 144: Roxlor LLC - Key offerings
• 12.13 Sirio Pharma Co. Ltd.
• Exhibit 145: Sirio Pharma Co. Ltd. - Overview
• Exhibit 146: Sirio Pharma Co. Ltd. - Product / Service
• Exhibit 147: Sirio Pharma Co. Ltd. - Key offerings
• 12.14 Suheung Co. Ltd.
• Exhibit 148: Suheung Co. Ltd. - Overview
• Exhibit 149: Suheung Co. Ltd. - Product / Service
• Exhibit 150: Suheung Co. Ltd. - Key offerings
• 12.15 Sunil Healthcare Ltd.
• Exhibit 151: Sunil Healthcare Ltd. - Overview
• Exhibit 152: Sunil Healthcare Ltd. - Product / Service
• Exhibit 153: Sunil Healthcare Ltd. - Key offerings
• 12.16 Thermo Fisher Scientific Inc.
• Exhibit 154: Thermo Fisher Scientific Inc. - Overview
• Exhibit 155: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 156: Thermo Fisher Scientific Inc. - Key news
• Exhibit 157: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 158: Thermo Fisher Scientific Inc. - Segment focus
• 12.17 Zeon Lifesciences Ltd.
• Exhibit 159: Zeon Lifesciences Ltd. - Overview
• Exhibit 160: Zeon Lifesciences Ltd. - Product / Service
• Exhibit 161: Zeon Lifesciences Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 162: Inclusions checklist
• Exhibit 163: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 164: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 165: Research methodology
• Exhibit 166: Validation techniques employed for market sizing
• Exhibit 167: Information sources
• 13.5 List of abbreviations
• Exhibit 168: List of abbreviations